Global Portal Hypertension Management Market Size study, by Treatment (Liver Transplantation, Endoscopic Therapy, Shunting Procedures, Drug Class), by End Users (Hospitals, Specialty Clinic, Others) and Regional Forecasts 2022-2032

Description

Global Portal Hypertension Management Market is valued at approximately USD 3.11 billion in 2023 and is anticipated to grow with a moderate growth rate of 5.02% over the forecast period 2024-2032. Portal hypertension, a condition marked by increased blood pressure within the portal venous system, necessitates a comprehensive approach to management involving both pharmacological and non-pharmacological treatments. Commonly utilized medications include beta-blockers and diuretics, which aim to reduce portal pressure and manage associated complications such as variceal bleeding and ascites. Additionally, endoscopic procedures such as band ligation are frequently employed to control bleeding varices, while advanced cases may require more invasive interventions such as trans jugular intrahepatic portosystemic shunt (TIPS) or liver transplantation. Alongside medical treatments, lifestyle modifications, including dietary sodium restrictions and alcohol cessation, play a pivotal role in managing this condition.

The market for Portal Hypertension Management is largely driven by the rising prevalence of liver diseases globally, an increasing awareness about the importance of early diagnosis, and significant advancements in minimally invasive treatment methods. Moreover, opportunities abound in the growing demand for innovative therapies, the expansion of healthcare infrastructure in emerging markets, and the development of personalized medicine strategies that could greatly enhance patient outcomes and broaden the market's reach. However, the market faces several challenges, including the high costs associated with treatment, restricted access to specialized care in lower-income regions, and the potential side effects of ongoing treatments.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the Portal Hypertension Management Market attributed to its advanced healthcare infrastructure and the growing demand for beta-blockers. The Asia-Pacific region, holding the second-largest market share, is expected to witness substantial growth due to rising incidences of liver diseases, increasing healthcare investments, and expanding patient populations, particularly in emerging economies.

Major market players included in this report are:

Chiasma Inc.
Genextra S.p.a.
Gilead Sciences Inc.
Debiovision, Inc.
Govind Ballabh Pant Hospital
Dr. Falk Pharma GmbH
Sun Pharmaceuticals Industries Ltd.
Ono Pharmaceutical Co., Ltd.
United Therapeutics Corporation
Novartis AG

The detailed segments and sub-segment of the market are explained below:

By Treatment:

Liver Transplantation
Endoscopic Therapy
Shunting Procedures
Drug Class

By End Users:

Hospitals
Specialty Clinic
Others

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico
RoLA

Middle East & Africa

Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Portal Hypertension Management Market Executive Summary

1.1. Global Portal Hypertension Management Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Treatment
- 1.3.2. By End Users
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Portal Hypertension Management Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Portal Hypertension Management Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Incidence of Liver Diseases
- 3.1.2. Rising Awareness about Early Diagnosis
- 3.1.3. Advancements in Minimally Invasive Treatments
3.2. Market Challenges
- 3.2.1. High Treatment Costs
- 3.2.2. Limited Access to Specialized Care in Low-Income Regions
3.3. Market Opportunities
- 3.3.1. Growing Demand for Innovative Therapies
- 3.3.2. Expanding Healthcare Infrastructure in Emerging Markets
- 3.3.3. Development of Personalized Medicine Approaches

Chapter 4. Global Portal Hypertension Management Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Portal Hypertension Management Market Size & Forecasts by Treatment 2022-2032

5.1. Segment Dashboard
5.2. Global Portal Hypertension Management Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Liver Transplantation
- 5.2.2. Endoscopic Therapy
- 5.2.3. Shunting Procedures
- 5.2.4. Drug Class

Chapter 6. Global Portal Hypertension Management Market Size & Forecasts by End Users 2022-2032

6.1. Segment Dashboard
6.2. Global Portal Hypertension Management Market: End Users Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Hospitals
- 6.2.2. Specialty Clinic
- 6.2.3. Others

Chapter 7. Global Portal Hypertension Management Market Size & Forecasts by Region 2022-2032

7.1. North America Portal Hypertension Management Market
- 7.1.1. U.S. Portal Hypertension Management Market
  - 7.1.1.1. Treatment breakdown size & forecasts, 2022-2032
  - 7.1.1.2. End Users breakdown size & forecasts, 2022-2032
- 7.1.2. Canada Portal Hypertension Management Market
7.2. Europe Portal Hypertension Management Market
- 7.2.1. U.K. Portal Hypertension Management Market
- 7.2.2. Germany Portal Hypertension Management Market
- 7.2.3. France Portal Hypertension Management Market
- 7.2.4. Spain Portal Hypertension Management Market
- 7.2.5. Italy Portal Hypertension Management Market
- 7.2.6. Rest of Europe Portal Hypertension Management Market
7.3. Asia-Pacific Portal Hypertension Management Market
- 7.3.1. China Portal Hypertension Management Market
- 7.3.2. India Portal Hypertension Management Market
- 7.3.3. Japan Portal Hypertension Management Market
- 7.3.4. Australia Portal Hypertension Management Market
- 7.3.5. South Korea Portal Hypertension Management Market
- 7.3.6. Rest of Asia Pacific Portal Hypertension Management Market
7.4. Latin America Portal Hypertension Management Market
- 7.4.1. Brazil Portal Hypertension Management Market
- 7.4.2. Mexico Portal Hypertension Management Market
- 7.4.3. Rest of Latin America Portal Hypertension Management Market
7.5. Middle East & Africa Portal Hypertension Management Market
- 7.5.1. Saudi Arabia Portal Hypertension Management Market
- 7.5.2. South Africa Portal Hypertension Management Market
- 7.5.3. Rest of Middle East & Africa Portal Hypertension Management Market

Chapter 8. Competitive Intelligence

8.1. Key Company SWOT Analysis
8.2. Top Market Strategies
8.3. Company Profiles
- 8.3.1. Chiasma Inc.
  - 8.3.1.1. Key Information
  - 8.3.1.2. Overview
  - 8.3.1.3. Financial (Subject to Data Availability)
  - 8.3.1.4. Product Summary
  - 8.3.1.5. Market Strategies
- 8.3.2. Genextra S.p.a.
- 8.3.3. Gilead Sciences Inc.
- 8.3.4. Debiovision, Inc.
- 8.3.5. Govind Ballabh Pant Hospital
- 8.3.6. Dr. Falk Pharma GmbH
- 8.3.7. Sun Pharmaceuticals Industries Ltd.
- 8.3.8. Ono Pharmaceutical Co., Ltd.
- 8.3.9. United Therapeutics Corporation
- 8.3.10. Novartis AG

Chapter 9. Research Process

9.1. Research Process
- 9.1.1. Data Mining
- 9.1.2. Analysis
- 9.1.3. Market Estimation
- 9.1.4. Validation
- 9.1.5. Publishing
9.2. Research Attributes